Indivior Pharmaceuticals (INDV) Shares Outstanding (Entity) (2021 - 2026)
Indivior Pharmaceuticals' Shares Outstanding (Entity) came in at 118.01 million for Q2 2026, down 5.4% from 124.77 million a year earlier and down 3.2% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
For FY2025, Indivior Pharmaceuticals' Shares Outstanding (Entity) was 125.07 million, up 0.3% from FY2024.
- Shares Outstanding (Entity) carries a four-year compound annual growth rate of -3.7% (FY2021 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 124.66 million in FY2024 (-8.7%), 136.53 million in FY2023 (unchanged), 136.48 million in FY2022 (-6.3%) and 145.66 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Shares Outstanding (Entity) in data going back to Q4 2021.
- Year-over-year, Shares Outstanding (Entity) increased in 1 of the last seven quarters, with an average decline of 5.3%.
- The fastest year-over-year change in Shares Outstanding (Entity) over five years came in Q4 2025 (growth of 0.3%), and the weakest in Q4 2024 (a decline of 8.7%).
- Business Quant data shows INDV's Shares Outstanding (Entity) at 121.92 million (Q1 2026), 125.07 million (Q4 2025) and 124.85 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Indivior Pharmaceuticals | 4.23 Bn | 3.19 Bn | 294.00 Mn | 118.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 118.01 Mn |
| Mar 31, 2026 | 121.92 Mn |
| Dec 31, 2025 | 125.07 Mn |
| Sep 30, 2025 | 124.85 Mn |
| Jun 30, 2025 | 124.77 Mn |
| Mar 31, 2025 | 124.77 Mn |
| Dec 31, 2024 | 124.66 Mn |
| Sep 30, 2024 | 132.00 Mn |
| Jun 30, 2024 | 135.00 Mn |
| Mar 31, 2024 | 136.00 Mn |
| Dec 31, 2023 | 136.53 Mn |
| Dec 31, 2022 | 136.48 Mn |
| Dec 31, 2021 | 145.66 Mn |
API Access
Indivior Pharmaceuticals Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();